Schechter Investment Advisors, LLC Dexcom Inc Transaction History

Schechter Investment Advisors, LLC

$977 Million
Q2 2024

A detailed history of Schechter Investment Advisors, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Schechter Investment Advisors, LLC holds 4,923 shares of DXCM stock, worth $335,305. This represents 0.06% of its overall portfolio holdings.

Number of Shares

4,923

Previous 4,236 16.22%

Holding current value

$335,305

Previous $587,000 4.94%

% of portfolio

0.06%

Previous 0.06%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$110.31 - $140.45 $75,782 - $96,489	687 Added 16.22%	4,923 $558,000
Q1 2024 May 06, 2024	BUY	$114.22 - $140.1 $5,254 - $6,444	46 Added 1.1%	4,236 $587,000
Q4 2023 Jan 17, 2024	SELL	$75.49 - $124.16 $46,652 - $76,730	-618 Reduced 12.85%	4,190 $519,000
Q3 2023 Nov 06, 2023	SELL	$86.06 - $137.93 $85,543 - $137,102	-994 Reduced 17.13%	4,808 $448,000
Q2 2023 Jul 26, 2023	SELL	$112.47 - $130.98 $96,949 - $112,904	-862 Reduced 12.94%	5,802 $745,000
Q1 2023 Apr 28, 2023	BUY	$104.0 - $122.92 $94,328 - $111,488	907 Added 15.75%	6,664 $774,000
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $173,869 - $250,982	2,046 Added 55.13%	5,757 $651,000
Q3 2022 Nov 04, 2022	SELL	$76.35 - $94.18 $136,742 - $168,676	-1,791 Reduced 32.55%	3,711 $299,000
Q2 2022 Nov 03, 2022	BUY	$67.99 - $132.89 $374,080 - $731,160	5,502 New	5,502 $410,000
Q1 2022 Nov 18, 2022	SELL	$94.08 - $130.2 $202,366 - $280,060	-2,151 Reduced 57.96%	1,560 $798,000
Q4 2021 Dec 27, 2022	SELL	$129.87 - $162.82 $266,623 - $334,269	-2,053 Reduced 55.32%	1,658 $890,000

Others Institutions Holding DXCM

# of Institutions

1,112

Shares Held

364M

Call Options Held

4.1M

Put Options Held

3.65M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schechter Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schechter Investment Advisors, LLC with notifications on news.

Account

Schechter Investment Advisors, LLC Dexcom Inc Transaction History